CN Patent

CN113474633A — 寡核苷酸配制方法

Assigned to Roche Innovation Center Copenhagen AS · Expires 2021-10-01 · 5y expired

What this patent protects

本发明涉及一种用于确定以粉末形式存在的寡核苷酸的量的方法。所述方法不需要实验确定所述寡核苷酸的消光系数、或连续稀释和A260测定。所述方法例如适用于经修饰的寡核苷酸，包括2’糖修饰的寡核苷酸、硫代磷酸寡核苷酸、报告基因标记的寡核苷酸和缀合的寡核苷酸。

USPTO Abstract

本发明涉及一种用于确定以粉末形式存在的寡核苷酸的量的方法。所述方法不需要实验确定所述寡核苷酸的消光系数、或连续稀释和A260测定。所述方法例如适用于经修饰的寡核苷酸，包括2’糖修饰的寡核苷酸、硫代磷酸寡核苷酸、报告基因标记的寡核苷酸和缀合的寡核苷酸。

Drugs covered by this patent

eplontersen-sodium (EPLONTERSEN SODIUM)

Patent Metadata

Patent number: CN113474633A
Jurisdiction: CN
Classification: —
Expires: 2021-10-01
Drug substance claim: No
Drug product claim: No
Assignee: Roche Innovation Center Copenhagen AS
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.